Related Experiment Video
Updated: Dec 2, 2025
Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide
Huijuan Jin1, Xiaojie Gao1, Li Xiao1
1Laboratory of Tumor Molecular and Cellular Biology, College of Life Sciences, Shaanxi Normal University, 620 West Chang'an Avenue, Xi'an, 710119, Shaanxi, China.
Objectives:
Breast cancer is a popular fatal malignant tumor for women with high of rates incidence and mortality. Development of the new approaches for breast cancer targeted diagnosis and chemotherapy is emergently needed by the current clinical practice, the important first step is finding a breast cancer specifically binding molecule or fragment as early clinical indicators.
Results:
By a phage-displayed peptide library, a 12-mer peptide, CSB1 was screened out using MCF-7 cells as the target. The consequently results under immunofluorescence and laser scanning confocal microscope (LSCM) indicated that CSB1 bound MCF-7 cells and breast cancer tissues specifically and sensitively with high affinity. Bioinformatics analysis suggested that the peptide CSB1 targets the 5-Lipoxygenase-Activating Protein (FLAP), which has been implicated in breast cancer progression and prognosis.
Conclusions:
The peptide, CSB1 is of the potential as a candidate to be used for developing the new approaches of molecular imaging detection and targeting chemotherapy of breast cancer in the future.
Insights
Researchers identified a novel peptide, CSB1, that specifically binds to breast cancer cells and tissues. This peptide shows potential for developing advanced diagnostic and therapeutic strategies for breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Breast cancer presents a significant global health challenge with high incidence and mortality rates in women.
- Current clinical practices urgently require novel targeted diagnostic and chemotherapeutic approaches for breast cancer.
- Identifying specific biomarkers for early detection and targeted therapy is a critical first step.
Purpose of the Study:
- To screen for a novel molecule with specific binding affinity to breast cancer cells.
- To evaluate the potential of identified molecules for targeted breast cancer diagnosis and therapy.
Main Methods:
- Utilized a phage-displayed peptide library to screen for specific binding peptides.
- Employed immunofluorescence and laser scanning confocal microscopy (LSCM) to assess binding.
- Conducted bioinformatics analysis to identify the molecular target of the selected peptide.
Main Results:
- A 12-mer peptide, designated CSB1, was successfully screened using MCF-7 cells.
- CSB1 demonstrated specific and sensitive binding to MCF-7 cells and breast cancer tissues with high affinity.
- Bioinformatics analysis indicated that CSB1 targets 5-Lipoxygenase-Activating Protein (FLAP), a protein implicated in breast cancer.
Conclusions:
- The peptide CSB1 exhibits potential as a candidate for developing innovative molecular imaging and targeted chemotherapy strategies for breast cancer.
- CSB1 could serve as an early clinical indicator for breast cancer detection.
- Further research into CSB1 may lead to improved breast cancer treatment modalities.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
13:49Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
Published on: December 6, 2017